Nonsurgical treatment of basal cell carcinomas with intralesional 5- fluorouracil/epinephrine injectable gel

Journal of the American Academy of Dermatology

Volumn 36, Issue 1, 1997, Pages 72-77

  Miller, B H ^a   Shavin, J S ^a   Cognetta, A ^a   Taylor, J R ^a   Salasche, S ^a   Korey, A ^a   Orenberg, E K ^a  

^a Clinical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INJECTION PAIN; INTRATUMORAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031038493     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)70328-1     Document Type: Article

References (15)

1. NY Yu EK Orenberg EE Luck Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice Cancer Chemother Pharmacol 36 1995 27 34
2. EK Orenberg EE Luck DM Brown Implant delivery system: intralesional delivery of chemotherapeutic agents for treatment of spontaneous skin tumors in veterinary patients Clin Dermatol 9 1992 561 568
3. AP Theon BR Madewell J Ryu Concurrent irradiation and intratumoral chemotherapy with cisplatin: a pilot study in dogs with spontaneous tumors Int J Radiat Oncol Biol Phys 29 1994 1027 1034
4. BE Kitchell EK Orenberg DM Brown Intralesional sustained-release chemotherapy with therapeutic implants for treatment of canine sun-induced squamous cell carcinoma Eur J Cancer 31 1995 2093 2098
5. BE Kitchell DM Brown EE Luck Intralesional implant for treatment of primary oral malignant melanoma in dogs J Am Vet Med Assoc 204 1994 229 236
6. EK Orenberg BH Miller HT Greenway The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma J Am Acad Dermatol 27 1992 723 728
7. HM Sturm Bowen's disease and 5-fluorouracil J Am Acad Dermatol 1 1979 513 522
8. DK Goette Topical chemotherapy with 5-fluorouracil J Am Acad Dermatol 4 1981 633 649
9. B Kurtis T Rosen Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU) J Dermatol Surg Oncol 6 1980 122 127
10. WH Avant RC Huff Intradermal 5-fluorouracil in the treatment of basal cell cancer of the face South Med J 69 1976 561 563
11. DK Goette RB Odom Successful treatment of keratoacanthoma with intralesional fluorouracil J Am Acad Dermatol 2 1980 212 216
12. Fluorouracil GK McEvoy American Hospital Formulacy Service Drug Information 573 1993 American Society of Hospital Pharmacists Bethesda, MD 7
13. WH Eaglstein GD Weinstein P Frost Fluorouracil: mechanism of action in human skin and actinic keratosis. 1. Effect on DNA synthesis in vivo Arch Dermatol 101 1970 132 139
14. 19 F-magnetic resonance spectroscopy to evaluate tumoral pharmacokinetics of AccuSite™ (fluorouracil/epinephrine) injectable gel for treatment of human basal cell carcinoma [abstract] Proc Am Assoc Cancer Res 35 1995 365
15. Swinehart J, Sperling M, Phillips S, et al. Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminata: a phase III clinical study. Arch Dermatol In press